TNSN98126A1 - Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan - Google Patents
Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptanInfo
- Publication number
- TNSN98126A1 TNSN98126A1 TNTNSN98126A TNSN98126A TNSN98126A1 TN SN98126 A1 TNSN98126 A1 TN SN98126A1 TN TNSN98126 A TNTNSN98126 A TN TNSN98126A TN SN98126 A TNSN98126 A TN SN98126A TN SN98126 A1 TNSN98126 A1 TN SN98126A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- eletriptan hemisulfate
- containing eletriptan
- hemisulfate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9714081.8A GB9714081D0 (en) | 1997-07-03 | 1997-07-03 | Pharmaceutical compositions |
GBGB9718270.3A GB9718270D0 (en) | 1997-07-03 | 1997-08-28 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98126A1 true TNSN98126A1 (fr) | 2005-03-15 |
Family
ID=10815339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98126A TNSN98126A1 (fr) | 1997-07-03 | 1998-07-01 | Compositions pharmaceutiques contenant de l'hemisulfate d'eletriptan |
Country Status (13)
Country | Link |
---|---|
KR (1) | KR100384346B1 (ko) |
AP (1) | AP1100A (ko) |
AR (1) | AR013165A1 (ko) |
CO (1) | CO4950555A1 (ko) |
GB (2) | GB9714081D0 (ko) |
GT (1) | GT199800105A (ko) |
HN (1) | HN1998000101A (ko) |
MY (1) | MY119643A (ko) |
PA (1) | PA8454501A1 (ko) |
PE (1) | PE84499A1 (ko) |
TN (1) | TNSN98126A1 (ko) |
UA (1) | UA49955C2 (ko) |
ZA (1) | ZA985812B (ko) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
-
1997
- 1997-07-03 GB GBGB9714081.8A patent/GB9714081D0/en active Pending
- 1997-08-28 GB GBGB9718270.3A patent/GB9718270D0/en active Pending
-
1998
- 1998-01-07 UA UA99126573A patent/UA49955C2/uk unknown
- 1998-06-30 PE PE1998000581A patent/PE84499A1/es not_active Application Discontinuation
- 1998-06-30 HN HN1998000101A patent/HN1998000101A/es unknown
- 1998-06-30 MY MYPI98002961A patent/MY119643A/en unknown
- 1998-07-01 PA PA19988454501A patent/PA8454501A1/es unknown
- 1998-07-01 TN TNTNSN98126A patent/TNSN98126A1/fr unknown
- 1998-07-01 AR ARP980103209A patent/AR013165A1/es unknown
- 1998-07-01 KR KR10-1999-7012523A patent/KR100384346B1/ko not_active IP Right Cessation
- 1998-07-02 AP APAP/P/1998/001290A patent/AP1100A/en active
- 1998-07-02 ZA ZA9805812A patent/ZA985812B/xx unknown
- 1998-07-03 CO CO98037816A patent/CO4950555A1/es unknown
- 1998-07-13 GT GT199800105A patent/GT199800105A/es unknown
Also Published As
Publication number | Publication date |
---|---|
UA49955C2 (uk) | 2002-10-15 |
GB9718270D0 (en) | 1997-11-05 |
AP9801290A0 (en) | 1998-09-30 |
MY119643A (en) | 2005-06-30 |
PA8454501A1 (es) | 2000-05-24 |
GT199800105A (es) | 2000-01-04 |
CO4950555A1 (es) | 2000-09-01 |
PE84499A1 (es) | 1999-09-11 |
AR013165A1 (es) | 2000-12-13 |
ZA985812B (en) | 2000-01-10 |
HN1998000101A (es) | 1999-01-08 |
KR100384346B1 (ko) | 2003-05-16 |
GB9714081D0 (en) | 1997-09-10 |
KR20010014366A (ko) | 2001-02-26 |
AP1100A (en) | 2002-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2549A1 (fr) | Compositions pharmaceutiques contenant de l'hémisulfate d'élétriptan. | |
Goodfield | Short‐duration therapy with terbinafine for dermatophyteonychomycosis: A multicentre trial | |
BE1002249A4 (fr) | Compositions pharmaceutiques. | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA27729A1 (fr) | Compositions pharmaceutiques solides contenant un agoniste des recepteurs de la s1p et un alcool de sucre | |
TNSN97044A1 (fr) | Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant. | |
TNSN98182A1 (fr) | Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97078A1 (fr) | Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant | |
TNSN99125A1 (fr) | Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98066A1 (fr) | Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99172A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN96172A1 (fr) | Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99126A1 (fr) | Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99170A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98227A1 (fr) | Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant. | |
EA200000299A1 (ru) | Лекарства | |
TNSN97087A1 (fr) | 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN96104A1 (fr) | Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant | |
MA26702A1 (fr) | Compositions pharmaceutiques pour le traitement de la migraine, et procede pour leur preparation | |
TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN01173A1 (fr) | Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda. | |
TNSN02018A1 (fr) | COMPOSITIONS COMPRENANT UN AGONISTE INVERSE DE GABAa, ET UN AGONISTE PARTIEL DES RECEPTEURS DE NICOTINE, UN OESTROGENE, UN MODULATEUR SELECTIF DES RECEPTEURS D'OESTROGENE OU DE LA VITAMINE E | |
TNSN98104A1 (fr) | Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
CA2231558A1 (fr) | Ligand antagoniste rar-.gamma. ou agoniste rar-.alpha. en tant qu'inhibiteur d'apoptose |